Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sarah_27_m
    Junior Member
    • Jan 2017
    • 4

    #1

    Using DeSeq2 with 16s data, valid parameters

    Hello,

    I am trying to use DeSeq2 in R to analyse differential abundance between 16s samples at OTU level. However I am not sure if the code I am using is valid for what I want to do. Codes comes from the phyloseq tutorial. http://joey711.github.io/phyloseq-ex...ns/DESeq2.html

    My data is 16s data (Illumima MiSeq), collected from birds with different caecal lesion scores (0, 1, 2, 3, 4) and uninfected controls, for each I have <10 biological replicates per group. What I am interested in doing in comparing abundance of OTUs across groups.

    I do as below to load my data into the matrix and then to ensure that I only have two groups (eg. 4 & uninfected) for comparison I remove the other groups using the subset option. Then run the code below.

    My question is, is subsetting like this still allowing the program to take all of the data, even that which isn't being compared, into account?

    Secondly am I struggling to know which parameters to use for this type of data with DeSeq2. Can I simply implement what is done for RnaSeq data here to look for differentially abundant OTUs or is this wrong completely? I am not sure which fitType to use; parametric or local or which test to use; Wald or LRT? Doing comparisons there is not much difference in the data, but would be good to know which is best to use.

    The reason I am using DeSeq2 is because I have a small data set, min of 8 biological replicates, max of 11 biological replicates per group.

    Having read the package manual I am still unclear. http://www.bioconductor.org/packages...man/DESeq2.pdf

    library("phyloseq")
    library("ggplot2")
    library("devtools")
    otufile=("table.from_biom_w_consensuslineage_0_replaced.txt")
    mapfile=("Mapping_file_LS.txt")
    trefile=("rep_set_tree.tre")
    qiimedata = import_qiime(otufile, mapfile, trefile)

    qiimedata = subset_samples(qiimedata, LesionScore != "0")
    qiimedata = subset_samples(qiimedata, LesionScore != "1")
    qiimedata = subset_samples(qiimedata, LesionScore != "2")
    qiimedata = subset_samples(qiimedata, LesionScore != "3")

    diagdds = phyloseq_to_deseq2(qiimedata, ~ LesionScore)
    diagdds = DESeq(diagdds, test="Wald", fitType="parametric")

    res = results(diagdds, cooksCutoff = FALSE)
    alpha = 0.05
    sigtab = res[which(res$padj < alpha), ]
    sigtab = cbind(as(sigtab, "data.frame"), as(tax_table(qiimedata)[rownames(sigtab), ], "matrix"))
    head(sigtab)
    sigtabOrdered <- sigtab[order(sigtab$padj),]
    plotMA(res)
    plotDispEsts(diagdds)


    Any help would be great
    Sarah
    Last edited by sarah_27_m; 01-06-2017, 06:54 AM.
  • sarah_27_m
    Junior Member
    • Jan 2017
    • 4

    #2
    The answer to part of my question, this demonstrates that microbiome count data from amplicon sequencing experiments can be treated with the same procedures as for differential expression data from RNA-Seq experiments.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:52 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Working...